MacroResearchBoard
| Independent Investment Strategy
health-care
U.S. Equities – Still Premature To Increase Defensive Positioning Beyond Health Care – October 24, 2023
· Equities ·
Defensive sectors such as utilities, consumer staples, and health care have all lagged the broad U.S. equity market year-to-date.
Regional Equities – Options For De-Risking From The Heavyweight U.S. – September 28, 2023
· Equities ·
Regional equity positioning is complicated by the outsized weight of the U.S. in the global equity benchmark…
U.S. Equities – It Gets Tougher From Here – May 16, 2023
· Equities ·
The 6-12 month outlook for the U.S. equity market remains uninspiring.
MRB TradeBook – Two New Equity Positions And One Closed Pair Trade – April 6, 2023
Absolute Return ·
Add to Favorite Reports
MRB TradeBook – Taking Profits – March 10, 2023
Absolute Return ·
Add to Favorite ReportsMarket volatility has caused us to take profits on three positions this week, these… Continue
Webinar – Investing In A Drawn-Out Late-Cycle Environment – (71min:13sec) – March 1, 2023
Webcasts & Webinars ·
Today’s MRB Webinar featured Salvatore Ruscitti discussing the outlook for the U.S. equity market and the implications of the late-cycle macro environment for portfolio positioning.
MRB TradeBook Update – Tactically Adding More Beta – October 28, 2022
Absolute Return ·
Add to Favorite Reports
Last Friday, the U.S. House of Representatives passed the Inflation Reduction Act.
Webcast – How Much Help Will Economic Stabilizers Provide? – (11min:53sec) – August 9, 2022
Webcasts & Webinars ·
In this week’s Webcast, global strategist Peter Perkins discusses the key drives of the capital market outlook for the next 6-12 months and MRB’s recommended asset allocation.
MRB TradeBook Update – Adding Beta & Tightening Stops – July 8, 2022
Absolute Return ·
Add to Favorite Reports
U.S. Equities – Health Care Stocks Remain A Core Defensive Holding – June 23, 2022
· Equities ·
U.S. health care stocks have outperformed the broad equity market year-to-date, led by the pharmaceuticals and biotechnology sub-groups
Regional Equities – Regional & Sectoral Balance For Turbulent Times – June 23, 2022
· Equities ·
The macro backdrop will remain challenging in the near term as investors assess the trade-off between elevated inflation and economic growth risks
MRB TradeBook Update – Elevated Volatility – June 17, 2022
Absolute Return ·
Add to Favorite Reports
U.S. Equities – Waiting For The Inflation Fever To Break – May 11, 2022
· Equities ·
U.S. stocks have corrected sharply year-to-date, with the rise in corporate earnings more than offset by a sharp multiple compression as bond yields have surged.
U.S. Equities – Continue To Favor U.S. Health Care Stocks Over Other Defensive Sectors – February 17, 2022
· Equities ·
The shift of monetary policy from ultra-accommodative towards normalization is ushering in a regime of greater volatility in the equity and bond markets
U.S. Equities – Taking Advantage Of Market Volatility – January 27, 2022
· Equities ·
U.S. equities have started the year on a turbulent note.
Webcast – Navigating The COVID-19 Roller Coaster – (9min:19sec) – December 1, 2021
Webcasts & Webinars ·
In this week’s Webcast, Salvatore Ruscitti discusses how the emergence of the Omicron variant impacts U.S. investment strategy
U.S. Equities – Setting The Tone For 2022 – November 24, 2021
· Equities ·
The overall macro backdrop will become less favorable for the equity market in the year ahead.
MRB TradeBook Update – August 13, 2021
Absolute Return ·
Add to Favorite Reports
The spreading COVID-19 Delta variant, looming Fed bond tapering, and headline risks associated with corporate tax increases are potential sources of equity market volatility in the coming weeks and months.
U.S. Equities – What The Bond Market Rout Means For U.S. Equities – March 2, 2021
· Equities ·
U.S. equity prices have been volatile of late due to a rapid rise in bond yields as government fixed-income markets have begun to discount stronger-than-expected economic growth and higher inflation.
Roundtable – U.S. Equity Sectors With Salvatore Ruscitti – January 28, 2021
Webcasts & Webinars ·
In this Roundtable, MRB’s U.S. Equity Strategist, Salvatore Ruscitti, discusses the outlook for the U.S. equity market and highlights our recommended sector positioning.
Absolute Return Strategy – Selectivity After The Runup – January 12, 2021
Absolute Return · ·
This report focuses on positioning around the potential for some near-term turbulence in global equity markets following the recent sharp upleg.
U.S. Sector Strategy – 2021 Outlook: From Rally To Rotation – December 23, 2020
· Equities ·
The expected widespread rollout of COVID-19 vaccines has boosted the outlook for the global economy.
U.S. Equities – Election Post-Mortem: The Implications For U.S. Equity Sectors – November 17, 2020
· Equities ·
The U.S. election will not be certified by the Electoral College until mid-December, but Joe Biden is almost certain to be the next president.
Absolute Return Strategy – The Ebb And Flow Of Uncertainty – November 12, 2020
Absolute Return · ·
There has been a clash all year between the countervailing forces of the sudden-stop recession and unprecedented policy reflation.
Absolute Return Strategy – The Opportunities Are In The Laggards – September 10, 2020
Absolute Return · ·
It has been a bumpy ride for investors over the past week as equities abruptly pulled back from overbought levels, before catching a bid yesterday.
U.S. Equities – Health Care Stocks: What’s At Stake In The Election? – August 13, 2020
· Equities ·
Health care is one of the most exposed sectors to the outcome of the November presidential election.
U.S. Equities – Follow The Profit Cycle – July 23, 2020
· Equities ·
The uncertainties unleashed by the COVID-19 pandemic pose a significant challenge for investment strategy.
U.S. Equities – Navigating The Growth Vs Value Style Imbalance – May 7, 2020
· Equities ·
Growth stocks have continued to exert market leadership this year amid the COVID pandemic.